131 related articles for article (PubMed ID: 24695349)
1. Aliphatic substitution of o-carboranyl phenols enhances estrogen receptor beta selectivity.
Ohta K; Ogawa T; Kaise A; Oda A; Endo Y
Chem Pharm Bull (Tokyo); 2014; 62(4):386-91. PubMed ID: 24695349
[TBL] [Abstract][Full Text] [Related]
2. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
[TBL] [Abstract][Full Text] [Related]
3. ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity.
Ohta K; Ogawa T; Kato K; Oda A; Endo Y
Bioorg Med Chem Lett; 2019 Aug; 29(16):2290-2293. PubMed ID: 31248773
[TBL] [Abstract][Full Text] [Related]
4. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.
Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL
J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of iodocarborane-containing ligands with high affinity and selectivity toward ERβ.
Ohta K; Ogawa T; Endo Y
Bioorg Med Chem Lett; 2017 Sep; 27(17):4030-4033. PubMed ID: 28778470
[TBL] [Abstract][Full Text] [Related]
6. Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity.
O'Boyle NM; Barrett I; Greene LM; Carr M; Fayne D; Twamley B; Knox AJS; Keely NO; Zisterer DM; Meegan MJ
J Med Chem; 2018 Jan; 61(2):514-534. PubMed ID: 28426931
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic activity of B-fluorinated o-carborane-1,2-bisphenol synthesized via S(N)Ar reaction.
Ohta K; Ogawa T; Endo Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4728-30. PubMed ID: 22695130
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal estrogen receptor isoform-selective biphenyls.
Bhatnagar S; Soni A; Kaushik S; Rikhi M; Santhoshkumar TR; Jayaram B
Chem Biol Drug Des; 2018 Feb; 91(2):620-630. PubMed ID: 29052968
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of estrogen receptor-beta selective ligands.
Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
[TBL] [Abstract][Full Text] [Related]
10. Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.
Zhang S; Wang Z; Hu Z; Li C; Tang C; Carlson KE; Luo J; Dong C; Katzenellenbogen JA; Huang J; Zhou HB
ChemMedChem; 2017 Feb; 12(3):235-249. PubMed ID: 27976818
[TBL] [Abstract][Full Text] [Related]
11. In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines.
Wang Z; Li Y; Ai C; Wang Y
Int J Mol Sci; 2010 Sep; 11(9):3434-58. PubMed ID: 20957105
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
[TBL] [Abstract][Full Text] [Related]
13. 3D models of MBP, a biologically active metabolite of bisphenol A, in human estrogen receptor α and estrogen receptor β.
Baker ME; Chandsawangbhuwana C
PLoS One; 2012; 7(10):e46078. PubMed ID: 23056236
[TBL] [Abstract][Full Text] [Related]
14. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.
Stauffer SR; Coletta CJ; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2000 Dec; 43(26):4934-47. PubMed ID: 11150164
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic effect of three substituted deoxybenzoins.
Chandrasekharan S; Bhaskar B; Muthiah R; Chandrasekharan AK; Ramamurthy V
Steroids; 2013 Feb; 78(2):147-55. PubMed ID: 23182765
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of azaisoflavone analogs as phytoestrogen mimetics.
Gim HJ; Li H; Jung SR; Park YJ; Ryu JH; Chung KH; Jeon R
Eur J Med Chem; 2014 Oct; 85():107-18. PubMed ID: 25078314
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.
Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC
Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic and antiestrogenic activities of 2,4-diphenylfuran-based ligands of estrogen receptors alpha and beta.
Zimmermann J; von Angerer E
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):259-68. PubMed ID: 17475477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
